New Conferences
(18 records)
Page 1 of 2Next>
Sort by :

   

Jun 14, 2017
Jul 31, 2017

QUALITY IMPROVEMENT (QI) AND PATIENT SAFETY IN ONCOLOGY

  • Understand the principles of Quality Improvement initiatives and how to start implementing projects in their own departments
  • Recognize factors leading to errors in practice and how to establish a positive safety culture in their own department
  • Design systems to evaluate practice and safety by using techniques such as systems theory and process control
Dr. Todd Pawlicki, PHD, FAAPM Professor and Vice-Chair of Medical Physics Division Director Department of Radiation Medicine and Applied Sciences University of California, San Diego
Quality Improvement, implementing projects, safety culture, Design systems
May 24, 2017
Jul 31, 2017

WHAT IS TIMELY TREATMENT INITIATION IN FOLLICULAR LYMPHOMA AND WHY IT MATTERS?!

  • Describe current initial treatment paradigms and associated outcomes for follicular lymphoma
  • Review current evidence regarding the prognostic factors/biomarkers in support of timely treatment initiation
  • Determine the key aspects of the clinician-patient communications related to treatment and its initiation
PIER LUIGI ZINZANI, MD, PHD Professor of Hematology Institute of Hematology "L. e A. Seràgnoli" University of Bologna Bologna, Italy
initial treatment, follicular lymphoma, prognostic factors/biomarkers, clinician-patient communications
May 18, 2017
Jul 31, 2017

INTEGRATED DIAGNOSIS OF LUNG CANCER - HOW CAN WE OBTAIN ALL THE USEFUL DIAGNOSTIC INFORMATION WITH A SMALL BIOPSY?

  • To understand the importance of molecular testing in the diagnosis and management of NSCLC
  • To be familiarized with new technologies that allow for more comprehensive molecular diagnoses
  • To appreciate how quantity of tissue impacts the molecular testing that can be done, and the trade-offs with minimizing procedural risks to patients
  • To discuss ways that ensure maximal diagnostic value is obtained when limited tissue is available
DR. MING-SOUND TSAO, FRCPC, MD
molecular testing, diagnosis and management of NSCLC new technologies, minimizing procedural risks to patients, discuss ways that ensure maximal diagnostic value
Apr 06, 2017
May 16, 2017

REVIEW AND NEW DEVELOPMENTS IN REFRACTORY OR RECURRENT INDOLENT LYMPHOMA

At the end of the session, the participant will be able to:
  • Identify the biological and clinical factors influencing treatment initiation as well as the choice of treatment for patients with relapsed or refractory disease.
  • Recognize the indication and management of toxicities associated with new available therapies.
  • Identify new future therapies for this population.
Pr. Gilles Salles (MD, PHD) Head of the Hematology Department Hospices Civils de Lyon Université Claude Bernard Lyon, France
relapsed or refractory disease, new available therapies
Apr 05, 2017
May 16, 2017

REVUE ET NOUVEAUTÉS DANS LE TRAITEMENT DES LYMPHOMES INDOLENTS RÉFRACTAIRES OU RÉCIDIVANTS

À la fin de cette activité, le participant sera capable:
  • D'identifier les facteurs biologiques et cliniques influençant la décision d'amorcer un traitement ainsi que du choix de traitements des patients avec maladie récidivante ou réfractaire.
  • De reconnaitre l'indication et de prendre en charge les toxicités associées aux nouveaux traitements disponibles.
  • D'identifier les nouvelles thérapies à venir pour cette population.
Pr. Gilles Salles (MD, PHD) Chef du service d’Hématologie Hospices Civils de Lyon Université Claude Bernard Lyon, France
maladie récidivante ou réfractaire, nouveaux traitements disponibles
Mar 30, 2017
May 16, 2017

BY SPECIAL REQUEST - ENDOCRINE DISRUPTORS IN OUR ENVIRONMENT

Dr. Joe Schwarcz
Mar 30, 2017
May 16, 2017

MUSCULO-SKELETAL - RATIONAL USE OF RHEUMATOLOGICAL TESTING

Approach to the use of laboratory tests for rheumatic diseases
Dr. Michael A. Stein
Laboratory serology rheumatoid factor antinuclear antibody anti-citrullinated proteins c-reactive protein sedimentation
Mar 16, 2017
May 16, 2017

APPROACH TO EXAMINING PATIENTS WITH COMMON NEUROLOGICAL PROBLEMS

The goal of the presentation is to outline and demonstrate:
  1. the basic skills necessary to perform a “screening” exam in neurology, and
  2. the basic skills necessary to perform a focused neurological exam on patients with common neurological problems.
Dr. Stuart Lubarsky
Neurological examination, weakness, tremor, cognitive impairment, vertigo, sensory symptoms
Mar 29, 2017
May 09, 2017

BY SPECIAL REQUEST - ALCOHOL AND SUBSTANCE ABUSE: WHAT IS NEW IN ADDICTION?

This presentation will be a review of three articles published in the past three years that are directly related to addiction medicine and have practical implications in the practice of family medicine.
Dr. David Luckow, MDCM, CFPC, DABAM, CMRO
Substance Use Disorder, Opioids, Prescriptions, Cannabis, Buprenorphone/ Naloxone
Mar 23, 2017
May 09, 2017

DERMATOLOGY - PAPULOSQUAMOUS DISEASES - PART 1

A presentation of the most commonly encountered papulosquamous diseases, with key features for diagnosis and differential diagnosis, and first-line treatments
Dr. Kevin Pehr
Dermatology. Treatment. Papulosquamous. Psoriasis. Pityriasis Rosea. Atopic eczema. Lichen Planus. Cutaneous T-Cell Lymphoma. Tinea Versicolor.

1 2 Next>


From Montreal, QC, Canada
Copyright © 2002-2017 Continuing Professional Development (CPD) Office,
Faculty of Medicine, McGill University